Current Report Filing (8-k)
July 17 2017 - 7:38AM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the
Securities
Exchange Act of 1934
Date
of Report (Date of earliest event reported): July 17, 2017
MEDICAL
TRANSCRIPTION BILLING, CORP.
(Exact
name of registrant as specified in its charter)
|
Delaware
|
|
333-192989
|
|
22-3832302
|
|
(State
or other jurisdiction
of
incorporation)
|
|
(Commission
File
Number)
|
|
(IRS
Employer
Identification
No.)
|
7
Clyde Road, Somerset, New Jersey, 08873
(Address of principal executive offices, zip code)
(732)
873-5133
(Registrant’s
telephone number, including area code)
Not
Applicable
(Former name or former address, if changed since last report)
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions:
|
[ ]
|
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
|
|
|
[ ]
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
|
|
|
[ ]
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
|
|
|
[ ]
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
|
Item
2.02
|
Results
of Operations and Financial Condition.
|
On
July 17, 2017, the Registrant issued a letter to shareholders, a copy of which is attached hereto as Exhibit 99.1 and is incorporated
herein by reference.
The
information furnished pursuant to Item 2.02 of this Form 8-K shall not be deemed “filed” for purposes of Section 18
of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) or otherwise subject to the liabilities of
that section, nor shall it be deemed incorporated by reference into any other filing under Securities Act of 1933, as amended
or the Exchange Act, except as expressly set forth by specific reference in such a filing.
|
Item
9.01
|
Financial
Statements and Exhibits.
|
|
Exhibit
99.1
|
Letter
to Shareholders dated July 17, 2017.
|
SIGNATURE(S)
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf
by the undersigned, hereunto duly authorized.
|
|
Medical Transcription Billing, Corp.
|
|
|
|
|
|
Date:
July 17, 2017
|
By:
|
/s/
Mahmud Haq
|
|
|
|
Mahmud
Haq
Chairman
of the Board and Chief Executive Officer
|
CareCloud (NASDAQ:MTBCP)
Historical Stock Chart
From Dec 2024 to Jan 2025
CareCloud (NASDAQ:MTBCP)
Historical Stock Chart
From Jan 2024 to Jan 2025
